- TheStreet.com•5 hours ago
While a phase III study progresses, Acceleron is searching for different populations of MDS patients where luspatercept might also be effective.
- Investor's Business Daily•2 days ago
Analysts are sharpening their pencils and coming up with more specifics on the impact of Trump corporate tax cuts on earnings and the stock market.
AMGN : Summary for Amgen Inc. - Yahoo Finance
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||140.19 x 100|
|Ask||145.00 x 1000|
|Day's Range||141.50 - 144.91|
|52 Week Range||133.64 - 176.85|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||14.42|
|Dividend & Yield||4.00 (2.78%)|
|1y Target Est||N/A|